Portfolio company
Forward Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Promakhos
This company develops oral small-molecule immunotherapies that restore immune system function to treat patients with chronic inflammatory diseases.
Immunic Therapeutics
The company develops oral therapies for chronic inflammatory and autoimmune diseases for patients with neurological and gastrointestinal conditions.
Promakhos Therapeutics
This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.
First Wave
The company develops oral and topical therapies targeting disease-causing immune cells to treat patients suffering from gastrointestinal and chronic inflammatory diseases.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
Matchpoint Therapeutics
This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.
DICE Therapeutics
This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.
IFM Therapeutics
The company develops small molecule medicines targeting the innate immune system to treat patients with inflammatory diseases and cancer.
